Consistent with previous reports demonstrating a role for STAT3 in mediating the epithelial-to-mesenchymal transition (EMT) of lung cancer cells, inhibition of STAT3 by cucurbitacin I also inhibits the migratory and metastatic ability of CD133+ CSCs in vivo [68,69]. Here, STAT3 is linked to lung cancer.